Literature DB >> 22210490

Evidence for a role of inhibition of orexinergic neurons in the anxiolytic and sedative effects of diazepam: A c-Fos study.

Anne E Panhelainen1, Esa R Korpi.   

Abstract

The classical benzodiazepine diazepam (DZ) induces anxiolysis at low doses and sedation and hypnosis at higher doses. Different brain areas and neuronal populations most likely mediate these different behavioral effects. We used c-Fos immunohistochemistry as an indirect way to study neuronal activation or inhibition induced by DZ at anxiolytic and sedative doses (0.5 and 5mg/kg, respectively) in various brain areas involved in anxiety, arousal, sedation and addiction in C57BL/6J mice. We also focused on the two neuronal populations, orexinergic and dopaminergic neuronal populations, with the help of double-immunohistochemistry using c-Fos and orexin-A antibodies and c-Fos and tyrosine hydroxylase antibodies. We found that different brain areas of unhabituated mice reacted differently to the mild stress induced by vehicle injection. Also the response to anxiolytic or sedative doses of DZ differed between the areas, suggesting that distinct brain areas mediate the behavioral effects of low and high DZ doses. Our findings propose a role for inhibition of orexin neurons in the anxiolytic and sleep-promoting effects of DZ. In addition, the activation of central amygdala neurons by DZ treatment was associated with anxiolytic and sedative effects. On the other hand, the ventral hippocampus, basolateral amygdala, ventral tegmental area and prefrontal cortex were sensitive even to the mild injection stress, but not to the anxiolytic dose of DZ.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22210490     DOI: 10.1016/j.pbb.2011.12.011

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  The brain orexin system and almorexant in fear-conditioned startle reactions in the rat.

Authors:  Michel A Steiner; Hugues Lecourt; Francois Jenck
Journal:  Psychopharmacology (Berl)       Date:  2012-05-17       Impact factor: 4.530

Review 2.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

3.  Orexin-A induces anxiety-like behavior through interactions with glutamatergic receptors in the bed nucleus of the stria terminalis of rats.

Authors:  Elizabeth A Lungwitz; Andrei Molosh; Philip L Johnson; Brian P Harvey; Rachel C Dirks; Amy Dietrich; Pamela Minick; Anantha Shekhar; William A Truitt
Journal:  Physiol Behav       Date:  2012-05-28

Review 4.  Exploring the Role of Orexinergic Neurons in Parkinson's Disease.

Authors:  Sachin Kumar; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Saurabh Bhatia; Ahmed Al-Harassi; Mohammed M Abdel-Daim; Simona Bungau
Journal:  Neurotox Res       Date:  2021-09-08       Impact factor: 3.911

5.  Blockade of corticotropin-releasing factor-1 receptors in the infralimbic cortex prevents stress-induced reinstatement of alcohol seeking in male Wistar rats: Evidence of interaction between CRF1 and orexin receptor signaling.

Authors:  Francisco J Flores-Ramirez; Alessandra Matzeu; Laura Sánchez-Marín; Rémi Martin-Fardon
Journal:  Neuropharmacology       Date:  2022-03-25       Impact factor: 5.273

Review 6.  The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.

Authors:  Morgan H James; Jennifer E Fragale; Shayna L O'Connor; Benjamin A Zimmer; Gary Aston-Jones
Journal:  Neuropharmacology       Date:  2020-10-19       Impact factor: 5.250

Review 7.  The contribution of orexins to sex differences in the stress response.

Authors:  Laura A Grafe; Seema Bhatnagar
Journal:  Brain Res       Date:  2018-08-03       Impact factor: 3.252

8.  GABAA receptor drugs and neuronal plasticity in reward and aversion: focus on the ventral tegmental area.

Authors:  Elena Vashchinkina; Anne Panhelainen; Teemu Aitta-Aho; Esa R Korpi
Journal:  Front Pharmacol       Date:  2014-11-25       Impact factor: 5.810

9.  Sexually Dimorphic Changes of Hypocretin (Orexin) in Depression.

Authors:  Jing Lu; Juan Zhao; Rawien Balesar; Rolf Fronczek; Qiong-Bin Zhu; Xue-Yan Wu; Shao-Hua Hu; Ai-Min Bao; Dick F Swaab
Journal:  EBioMedicine       Date:  2017-03-31       Impact factor: 8.143

10.  The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.

Authors:  Yih-Shou Hsieh; Pei-Ni Chen; Ching-Han Yu; Jiuan-Miaw Liao; Dong-Yih Kuo
Journal:  Mol Brain       Date:  2013-11-13       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.